The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

BACKGROUND: The promotility agents currently available to treat gastroparesis and feed intolerance in the critically ill are limited by adverse effects. The aim of this study was to assess the pharmacodynamic effects and pharmacokinetics of single doses of the novel gastric promotility agent motilin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Marianne J., Deane, Adam M., O’Connor, Stephanie L., Nguyen, Nam Q., Fraser, Robert J. L., Richards, Duncan B., Hacquoil, Kimberley E., Vasist Johnson, Lakshmi S., Barton, Matthew E., Dukes, George E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967996/
https://www.ncbi.nlm.nih.gov/pubmed/27476581
http://dx.doi.org/10.1186/s13054-016-1420-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967996/
https://www.ncbi.nlm.nih.gov/pubmed/27476581
http://dx.doi.org/10.1186/s13054-016-1420-4

Ejemplares similares